IHL (ASX) Share your ideas and thoughts.

Originally posted by MrFantastic: ↑

On another note, IHL are not just in idea phase and to say this is pushing miss information mate. Plus to say that the share price will be diluted when some options are taken is also spreading misinformation, because you don’t know this, as it hasn’t happened yet!

Two thirds of your post is pushing the fear agenda and then you say it’s a great time to buy? Very confusing post mate! I understand being cautious, but IHL are way past the idea phase of the game. Trying to understand your agenda here? But from reading a few of your post on other stocks it is becoming clearer. Each to their own I guess?

Expand

Gday Mr F.

Sorry for the delay. Time zone is 7hrs behind over here.

I think Philm answered most of your questions.

I didnt mean to create fear. If i did I apologise. I have a reasonably large holding of IHL, with both heads and oppies. In fact after some recent oppie purchases I hold more of this than that other share of mine you refer to.

There is always risk with spec stocks. You can mitigate this with research, who is running the company? Where does their product fit in the market? What is their MC like compared to peers? What else is in the pipeline etc. So I think when this is all considered we are in a space. But their is still risk until the product is commercialised.

The timeline from pre clinical to end of trial can be a long one. That other share that I hold has a few pre clinical cancer products that have pre clinical for almost two years. One trial that commenced early to mid last year is forcast to give results by the end of next month. So it all needs time. And that is normal.

We should expect an announcement that approval for trial is given. Then that they recruiting for the trial, and then when first patient is dosed. So a few announcements yet until we are underway.

Also I think someone else has already mentioned that the oil sales dont seem to be fully factored into the price yet. I would expect some movement of share price after the next quarterly if they keep the growth rate of this like the last quarter.